Guillain-Barré syndrome diagnostic study of choice: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
** [[Areflexia]] or decreased reflexes in affected limbs. | ** [[Areflexia]] or decreased reflexes in affected limbs. | ||
* these findings can make the GBS diagnosis even more possible: | * these findings can make the GBS diagnosis even more possible: | ||
** Progression of symptoms over days to four weeks | ** Progression of [[symptoms]] over days to four weeks | ||
** Relative symmetry | ** Relative symmetry | ||
** Sensory abnormalities | ** Sensory abnormalities | ||
** Cranial nerve involvement, especially bilateral facial nerve weakness | ** Cranial nerve involvement, especially bilateral facial nerve weakness | ||
** Recovery starting two to four weeks after progression stops | ** Recovery starting two to four weeks after progression stops | ||
** Autonomic disturbance | ** [[Autonomic dysfunction|Autonomic disturbance]] | ||
** Pain | ** [[Pain]] | ||
** absence of fever in the acute phase | ** absence of fever in the acute phase | ||
** Elevated CSF protein level | ** Elevated [[CSF]] protein level | ||
** CSF cell count ≤50/mm<sup>3</sup> | ** CSF cell count ≤50/mm<sup>3</sup> | ||
** Electrodiagnostic abnormalities consistent with GBS | ** Electrodiagnostic abnormalities consistent with GBS | ||
Revision as of 15:08, 27 December 2018
|
Guillain-Barré syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Guillain-Barré syndrome diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Guillain-Barré syndrome diagnostic study of choice |
|
Guillain-Barré syndrome diagnostic study of choice in the news |
|
Risk calculators and risk factors for Guillain-Barré syndrome diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
Diagnostic Study of Choice
Diagnostic Criteria
- There is no single diagnostic study of choice for Guillain Barre syndrome, though GBS may be diagnosed based on NINDS criteria established by National Institute of Neurological Disorders and Stroke:[1][2]
- these findings can make the GBS diagnosis even more possible:
- Progression of symptoms over days to four weeks
- Relative symmetry
- Sensory abnormalities
- Cranial nerve involvement, especially bilateral facial nerve weakness
- Recovery starting two to four weeks after progression stops
- Autonomic disturbance
- Pain
- absence of fever in the acute phase
- Elevated CSF protein level
- CSF cell count ≤50/mm3
- Electrodiagnostic abnormalities consistent with GBS